Funders · Entity Annotation Prototype (beta)

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: North East - York Research Ethics Committee ×

North East - York Research Ethics Committee

This funder is selected. Its supporting articles are shown below.

North East - York Research Ethics Committee1

Articles mentioning North East - York Research Ethics Committee

1 articles · page 1 of 1

578 A First-in-human phase I/IIa dose escalation trial evaluating the safety and preliminary efficacy of LEU011, a novel CAR-T, in subjects with relapsed/refractory solid tumors (AERIAL)

jitc · abstract · 2025-11-04 · 1 matching annotations

83.1%

ClinicalTrials.gov North East - York Research Ethics Committee LEU011 solid tumors solid tumours LEU01101 lymphodepleting chemotherapy LDC

…eliminary Efficacy of LEU011 in Solid Tumours’ is registered at ClinicalTrials.gov with the unique reference number NCT06193902Ethics Approval Eth…

Browse funders

North East - York Research Ethics Committee

Articles mentioning North East - York Research Ethics Committee

578 A First-in-human phase I/IIa dose escalation trial evaluating the safety and preliminary efficacy of LEU011, a novel CAR-T, in subjects with relapsed/refractory solid tumors (AERIAL)